The Medical Research Council, in partnership with AstraZeneca, invites proposals under its mechanisms of disease initiative.
Through this initiative, UK academic researchers will have access to a high-quality collection of AstraZeneca compounds that can be used to support studies to investigate human mechanisms of disease and the development of potential therapeutic interventions.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.